BioSpace News Archive

Avrio Health L.P. (Avrio), a subsidiary of Purdue Pharma L.P. (Purdue), today announced the launch of new Betadine® Antiseptic Sore Throat Gargle (active ingredient povidone-iodine, or PVP-I), an oral antiseptic with use for the temporary relief of occasional sore throat.

JAN101 formulation ready for Phase 2b peripheral artery disease trials and for potential treatment of COVID-19 vascular inflammation

Rite Aid has deepened its bench of health industry leaders with the appointment of two new executives: Roxanne Schwans has joined the company to lead market access and pharmacy purchasing, and Chris Bohrer has joined to build out Rite Aid’s health plan solutions business and strategic initiatives.

A leading emergency physician and POCUS educator, Dr. Oron Frenkel is an advocate for replacing stethoscopes with handheld ultrasound scanners to improve patient care.

The NIAID funded grant will help advance AUM LifeTech’s preclinical program on HIV therapy using self-delivering RNA silencing technology

Immuneering Corporation announced the company’s participation in Oppenheimer’s Private Life Sciences Company Call Series taking place virtually August 17-19, 2020.

Chemotherapy usually cures children diagnosed with acute lymphoblastic leukemia, but the treatment may hamper brain development and impact key cognitive functions including sensory processing, memory, and attention.

Aesculap, Inc. is sponsoring the symposium as part of its participation in the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Virtual Meeting [11-August-2020] CENTER VALLEY, Pa. , Aug. 11, 2020 /PRNewswire/ -- Aesculap, Inc. is pleased to announce its participation as a virtual exhibitor at the 2020 Society of American Gastrointestinal and Endosc

BPT Analytics Ltd. (BiopharmaTrend) a provider of web-based business intelligence dashboards for the pharmaceutical industry, launched cloud-based analytics dashboard “A Landscape of Artificial Intelligence (AI) In Pharma R&D”,

The Alzheimer’s Foundation of America has awarded $518,391 in research grant funding to the Broad Institute of MIT and Harvard and One Mind, partners on a three-year study to examine the role of the brain’s immune cells in the onset and progression of Alzheimer’s disease.